Work

Patterns of pembrolizumab use for recurrent cervical cancer.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.e17528

Authors: Yongmei Huang, Katherine Yoh, Elizabeth A. Szamreta, Xiao Xu, Dawn L. Hershman, Jason Dennis Wright

Institutions: Columbia University Irving Medical Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Herbert Irving Comprehensive Cancer Center

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400413675

Cites:

Cited by:

Related to: 10